Combining statistical parametric maps (SPM) from individual subjects is the goal in some types of group-level analyses of functional magnetic resonance imaging data. Brain maps are usually combined using a simple average across subjects, making them susceptible to subjects with outlying values. Furthermore, t tests are prone to false positives and false negatives when outlying values are observed. We propose a regularized unsupervised aggregation method for SPMs to find an optimal weight for aggregation, which aids in detecting and mitigating the effect of outlying subjects. We also present a bootstrap-based weighted t test using the optimal weights to construct an activation map robust to outlying subjects. We validate the performance of the proposed aggregation method and test using simulated and real data examples. Results show that the regularized aggregation approach can effectively detect outlying subjects, lower their weights, and produce robust SPMs.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6865509PMC
http://dx.doi.org/10.1002/hbm.24355DOI Listing

Publication Analysis

Top Keywords

outlying subjects
12
regularized aggregation
8
statistical parametric
8
parametric maps
8
outlying values
8
aggregation method
8
subjects
6
outlying
5
aggregation statistical
4
maps combining
4

Similar Publications

FDA experiences with a centralized statistical monitoring tool.

J Biopharm Stat

October 2024

FDA/CDER/OTS/OB/DAI (Food and Drug Administration, Center for Drug Evaluation and Research, Office of Translational Sciences, Office of Biostatistics, Division of Analytics and Informatics), Silver Spring, Maryland, United States.

The U.S. Food and Drug Administration (FDA) has broadly supported quality by design initiatives for clinical trials - including monitoring and data validation - by releasing two related guidance documents (FDA 2013 and 2019).

View Article and Find Full Text PDF

Diagnostics for a two-stage joint survival model.

Commun Stat Simul Comput

October 2021

Department of Statistical Sciences, University of Cape Town, Cape Town, South Africa.

A two-stage joint survival model is used to analyse time to event outcomes that could be associated with biomakers that are repeatedly collected over time. A Two-stage joint survival model has limited model checking tools and is usually assessed using standard diagnostic tools for survival models. The diagnostic tools can be improved and implemented.

View Article and Find Full Text PDF

Background: Multiple Sclerosis (MS) is a chronic autoimmune disease, affecting over 2.5 million people worldwide. There has been growing concern about the impact of COVID-19 on the clinical course of MS.

View Article and Find Full Text PDF

Analyzing microbial evolution through gene and genome phylogenies.

Biostatistics

July 2024

University of Washington Department of Biostatistics, Hans Rosling Center for Population Health, Box 351617, Seattle, WA 98195-1617, USA.

Microbiome scientists critically need modern tools to explore and analyze microbial evolution. Often this involves studying the evolution of microbial genomes as a whole. However, different genes in a single genome can be subject to different evolutionary pressures, which can result in distinct gene-level evolutionary histories.

View Article and Find Full Text PDF

Microbiome scientists critically need modern tools to explore and analyze microbial evolution. Often this involves studying the evolution of microbial genomes as a whole. However, different genes in a single genome can be subject to different evolutionary pressures, which can result in distinct gene-level evolutionary histories.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!